Clinical Trial: Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With Zidovudine

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Double-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex

Brief Summary: To compare the efficacy and safety of orally administered didanosine (ddI) with orally administered zidovudine (AZT) in the treatment of patients who exhibit increasing clinical deterioration despite treatment with AZT.

Detailed Summary:
Sponsor: Bristol-Myers Squibb

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Bristol-Myers Squibb

Dates:
Date Received: November 2, 1999
Date Started:
Date Completion:
Last Updated: August 4, 2011
Last Verified: August 2011